Ellen Rose
Investor Relations Contact bei LYELL IMMUNOPHARMA, INC.
Profil
Ellen Rose is currently the Senior VP-Communications & Investor Relations at Lyell Immunopharma, Inc. She previously worked as the Director-Communications at ALZA Corp.
and as the Head-Communications & Media Relations at Prothena Corp.
Plc.
Ms. Rose completed her undergraduate degree at Stanford University.
Aktive Positionen von Ellen Rose
| Unternehmen | Position | Beginn |
|---|---|---|
| LYELL IMMUNOPHARMA, INC. | Investor Relations Contact | 01.04.2021 |
Ehemalige bekannte Positionen von Ellen Rose
| Unternehmen | Position | Ende |
|---|---|---|
| ALZA CORPORATION | Public Communications Contact | - |
| PROTHENA CORPORATION PLC | Public Communications Contact | - |
Ausbildung von Ellen Rose
| Stanford University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| PROTHENA CORPORATION PLC | Health Technology |
| LYELL IMMUNOPHARMA, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
ALZA Corp.
 ALZA Corp. Pharmaceuticals: MajorHealth Technology ALZA Corp. provides drug delivery solutions and develops pharmaceutical products. The company applies its delivery technologies to develop pharmaceutical products with enhanced therapeutic value for its own portfolio and for many of the world's leading pharmaceutical companies. The company was founded by Martin Gerstel and Alejandro Zaffaroni in 1968 and is headquartered in Vacaville, CA. | Health Technology |
